Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 46

Results For "MD"

2310 News Found

GlycoNex wins Japan nod to launch first human trial of lead program in gastrointestinal cancers
Clinical Trials | April 16, 2026

GlycoNex wins Japan nod to launch first human trial of lead program in gastrointestinal cancers

The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy


Botanic Healthcare appoints Kamalakar V. Arcot as Group CEO
People | April 15, 2026

Botanic Healthcare appoints Kamalakar V. Arcot as Group CEO

Arcot is a seasoned executive with more than two decades of experience across the global pharma and life sciences sectors


Experts call for precision diagnosis and standardised neonatal protocols
Hospitals | April 15, 2026

Experts call for precision diagnosis and standardised neonatal protocols

The perinatology CME at Navi Mumbai brought together more than 100 obstetricians, pediatricians, and neonatologists


Healync Technologies secures Volrado Venture investment to build next-generation digital hospital infrastructure
Hospitals | April 15, 2026

Healync Technologies secures Volrado Venture investment to build next-generation digital hospital infrastructure

Funding to accelerate growth of concierge-style private health services and Aayu’s paperless hospital infrastructure platform


NantBioRenewables expands US manufacturing footprint in Alabama
Biotech | April 15, 2026

NantBioRenewables expands US manufacturing footprint in Alabama

To boost compostable packaging, resin innovation, and supply chain speed


Novo Nordisk and OpenAI forge major AI alliance to accelerate drug discovery & healthcare operations
R&D | April 15, 2026

Novo Nordisk and OpenAI forge major AI alliance to accelerate drug discovery & healthcare operations

The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations


MSN Laboratories launches SEMABEST, India-made semaglutide pen at nearly 50% lower price
Drug Approval | April 15, 2026

MSN Laboratories launches SEMABEST, India-made semaglutide pen at nearly 50% lower price

CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing


MedLern partners with Godrej Memorial Hospital to strengthen accreditation-led workforce training
Hospitals | April 15, 2026

MedLern partners with Godrej Memorial Hospital to strengthen accreditation-led workforce training

Collaboration aims to align hospital staff learning with NABH 6th Edition standards, patient safety, and measurable quality outcomes


ten23 health expands APAC footprint with new Tokyo office, appoints Noriko Utsumi
Biotech | April 15, 2026

ten23 health expands APAC footprint with new Tokyo office, appoints Noriko Utsumi

Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region


CDSCO invites bids for next-gen Digital Drugs Regulatory System
Drug Approval | April 15, 2026

CDSCO invites bids for next-gen Digital Drugs Regulatory System

API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India